Wake Forest Baptist - Comprehensive Cancer Center
Atrium Health
Winston-Salem, NC
Accepting patients
Etentamig
A Study to Assess Adverse Events of Intravenously (IV) Infused ABBV-383 in Adult Participants With Relapsed or Refractory Multiple Myeloma
- Bispecific Antibody
- BCMA
- Phase 1
- Has results
Accepting patients
Linvoseltamab
A Study to Examine the Effects of Novel Therapy Linvoseltamab in Combination With Other Cancer Treatments for Adult Patients With Multiple Myeloma That is Resistant to Current Standard of Care Treatments
- Bispecific Antibody
- BCMA
- Phase 1
All clinical trials have eligibility criteria - or a list of reasons why you may be able or unable to participate in a trial. Answer a few questions to view your personalized results - all in under 60 seconds.
Help me find trialsAccepting patients
Chemosensitivity Study
Novel 3D Hematological Malignancy Organoid to Study Disease Biology and Chemosensitivity (Organoid)
Accepting patients
Patient Registry: Undergoing Stem Cell Transplant
The Prospective Collection, Storage and Reporting of Data on Patients
- Patient Registry
- Observational Trial
Accepting patients
IDP-023
Phase 1/2 Study of IDP-023 as a Single Agent and in Combination With Antibody Therapies in Patients With Advanced Hematologic Cancers
- Natural Killer Cells (Allogeneic)
- Phase 1/2
Accepting patients
Nivolumab Post Treatment with Ide-Cel
Nivolumab As An Adjunctive Therapy In Relapsed Refractory Multiple Myeloma Patients With Sub-Optimal Response To Idecabtagene Vicleucel
- Checkpoint Inhibitor
- Monoclonal Antibody
- PD-1
- Phase 2
Accepting patients
Etentamig
A Multicenter, Phase 1b, Open-label Study of ABBV-383 Administered Subcutaneously in Subjects With Relapsed or Refractory Multiple Myeloma
- Bispecific Antibody
- BCMA
- Phase 1
Accepting patients
Belantamab Mafodotin
Study of Carfilzomib, Lenalidomide, Dexamethasone and Belantamab Mafodotin in Multiple Myeloma
- Antibody Drug Conjugate (ADC)
- BCMA
- High Risk
- Phase 1/2
- Has results
1 hidden based on your filters. Show All